Nanoscope Therapeutics Inc today announced that management will present at the BIO International Convention, taking place June 3-6, 2024, in San Diego, California.
DALLAS, May 29, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that management will present at the BIO International Convention, taking place June 3-6, 2024, in San Diego, California. Details for the presentations are as follows: Session Date: Wednesday, June 5, 2024 Ms. Bhattacharya presently serves on the board of directors of BIO. In her presentation, she will highlight Nanoscope’s Multi-Characteristic Opsin platform and give an overview of the Company’s mutation-agnostic approach. She will also detail the Company’s ongoing corporate activities. Nanoscope leadership will be available for meetings during the conference. About Nanoscope Therapeutics Inc. Investor Contact: View original content to download multimedia:https://www.prnewswire.com/news-releases/nanoscope-therapeutics-to-present-at-the-bio-international-convention-302157137.html SOURCE Nanoscope Therapeutics |